<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-09T11:13:04+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>罗氏CD20×CD3双抗一线治疗DLBCL，完全缓解率79%</title>
    <updated>2020-12-09T08:39:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/I1KyiC8FJM4kc6kAf_ZGgw</id>
    <link href="https://mp.weixin.qq.com/s/I1KyiC8FJM4kc6kAf_ZGgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和黄医药于上海张江举行创新药生产基地开工仪式</title>
    <updated>2020-12-09T08:39:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/wAcPicIpzTkygWFS8-51Mg</id>
    <link href="https://mp.weixin.qq.com/s/wAcPicIpzTkygWFS8-51Mg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东曜药业公布ADC药物TAA013 I期研究结果</title>
    <updated>2020-12-09T08:39:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/By3zfNWYafpt6QAG7BOmyw</id>
    <link href="https://mp.weixin.qq.com/s/By3zfNWYafpt6QAG7BOmyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>凌腾医药宣布于10月6日完成卡妥索胃癌全球III期临床研究第一阶段首例患者给药</title>
    <updated>2020-12-09T08:39:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/_2kclkG5FHDfVUk5NF3tlQ</id>
    <link href="https://mp.weixin.qq.com/s/_2kclkG5FHDfVUk5NF3tlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10年上市3款单抗生物药，复宏汉霖进入新征程</title>
    <updated>2020-12-08T07:41:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/CK16LIHlhUIuuGVaD6FK1w</id>
    <link href="https://mp.weixin.qq.com/s/CK16LIHlhUIuuGVaD6FK1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science子刊揭秘：抑制肿瘤复发的秘密武器——β受体阻滞剂</title>
    <updated>2020-12-08T07:41:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/qDp8blrxFU7DYcWbBB7uBw</id>
    <link href="https://mp.weixin.qq.com/s/qDp8blrxFU7DYcWbBB7uBw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>锐明新药完成数千万元A轮融资！加速推动wAMD项目申报和后续管线产品开发</title>
    <updated>2020-12-08T07:41:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/DW-uW0UX1-lEi8urbBnbNg</id>
    <link href="https://mp.weixin.qq.com/s/DW-uW0UX1-lEi8urbBnbNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药宣布ATG-010与R-GDP联合用于治疗复发难治性弥漫性大B细胞淋巴瘤的全球多中心2/3期临床试验申请获中国药监局受理</title>
    <updated>2020-12-08T07:41:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/wYSHeR6Ebl61jBs7UWZ7Ig</id>
    <link href="https://mp.weixin.qq.com/s/wYSHeR6Ebl61jBs7UWZ7Ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020ASH】亚盛医药公布抗耐药白血病新药HQP1351（奥瑞巴替尼）关键性注册II 期研究的积极数据</title>
    <updated>2020-12-08T07:41:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/H1uHuNngo7bNuctUp-34gg</id>
    <link href="https://mp.weixin.qq.com/s/H1uHuNngo7bNuctUp-34gg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向CD47：小分子可堪重任？</title>
    <updated>2020-12-07T07:41:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/G3o_VTVSELBZ58ZuKUZasA</id>
    <link href="https://mp.weixin.qq.com/s/G3o_VTVSELBZ58ZuKUZasA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三叶草生物发布“S-三聚体”重组亚单位新冠候选疫苗 I 期研究积极结果</title>
    <updated>2020-12-07T07:41:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/mdBVjap4pYhL8wsgilTI8g</id>
    <link href="https://mp.weixin.qq.com/s/mdBVjap4pYhL8wsgilTI8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：医学经理</title>
    <updated>2020-12-07T07:41:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/6t3JX-pUMMyRzzDHoQm7zw</id>
    <link href="https://mp.weixin.qq.com/s/6t3JX-pUMMyRzzDHoQm7zw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>司美鲁肽减肥适应症申请上市！每周皮下注射1次，68周减重18%</title>
    <updated>2020-12-05T10:48:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/JcIW5Mkjun9lROyKUr0VwA</id>
    <link href="https://mp.weixin.qq.com/s/JcIW5Mkjun9lROyKUr0VwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>强生EGFR/c-Met双抗凭I期数据申请上市</title>
    <updated>2020-12-04T07:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/aC3iUMrZZWN0vbnTCp-fyw</id>
    <link href="https://mp.weixin.qq.com/s/aC3iUMrZZWN0vbnTCp-fyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>分析师预测：新冠疫苗2021年销售额可达380亿美元</title>
    <updated>2020-12-04T07:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/ZVB_n-5ZQaxsaHqNx5fDtw</id>
    <link href="https://mp.weixin.qq.com/s/ZVB_n-5ZQaxsaHqNx5fDtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新！注射剂一致性评价排行榜</title>
    <updated>2020-12-04T07:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/IN5u76gov9sRKBtq2A_vrQ</id>
    <link href="https://mp.weixin.qq.com/s/IN5u76gov9sRKBtq2A_vrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药在多个亚太市场提交XPOVIO®（Selinexor）的新药上市申请用于治疗复发难治性多发性骨髓瘤和弥漫性大B细胞淋巴瘤</title>
    <updated>2020-12-04T07:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/6DIfvpQGwK6YHjvSip4JRg</id>
    <link href="https://mp.weixin.qq.com/s/6DIfvpQGwK6YHjvSip4JRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛医药任命祝刚先生为首席商务运营官，全面启动商业化布局</title>
    <updated>2020-12-04T07:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/D8mMbE4pyOAAK4jkHO7kyw</id>
    <link href="https://mp.weixin.qq.com/s/D8mMbE4pyOAAK4jkHO7kyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代溶瘤病毒主攻的三大方向</title>
    <updated>2020-12-03T07:47:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/ccLHfYGmGogTmVI9n9YHyA</id>
    <link href="https://mp.weixin.qq.com/s/ccLHfYGmGogTmVI9n9YHyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年11月│失败临床研究TOP5</title>
    <updated>2020-12-03T07:47:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/kYCOwcx95VTM1HcUz8nfiw</id>
    <link href="https://mp.weixin.qq.com/s/kYCOwcx95VTM1HcUz8nfiw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>